60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Short Interest Update

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 1,382 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average trading volume of 26,420 shares, the short-interest ratio is currently 0.1 days.

60 Degrees Pharmaceuticals Price Performance

Shares of SXTPW traded down $0.00 during mid-day trading on Monday, hitting $0.04. The company had a trading volume of 1,730 shares, compared to its average volume of 14,175. The business’s 50-day simple moving average is $0.06 and its 200-day simple moving average is $0.06. 60 Degrees Pharmaceuticals has a 1-year low of $0.03 and a 1-year high of $0.16.

60 Degrees Pharmaceuticals Company Profile

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.